NM_000535.7:c.2152C>T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_000535.7(PMS2):c.2152C>T(p.Leu718Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000373 in 1,608,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151634Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1457200Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 724862
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151634Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74060
ClinVar
Submissions by phenotype
not provided Uncertain:1
The PMS2 c.2152C>T (p.Leu718Phe) variant has not been reported in individuals with PMS2-related conditions in the published literature. The frequency of this variant in the general population, 0.000032 (1/31138 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is deleterious or benign. Based on the available information, we are unable to determine the clinical significance of this variant. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 718 of the PMS2 protein (p.Leu718Phe). The frequency data for this variant in the population databases (gnomAD) is considered unreliable due to the presence of homologous sequence, such as pseudogenes or paralogs, in the genome. This variant has not been reported in the literature in individuals affected with PMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 455686). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) indicates that this missense variant is not expected to disrupt PMS2 function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.L718F variant (also known as c.2152C>T), located in coding exon 12 of the PMS2 gene, results from a C to T substitution at nucleotide position 2152. The leucine at codon 718 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Lynch syndrome 4 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at